Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
A multicenter, open-label, prospective study to evaluate the safety and efficacy of
leuprorelin acetate DPS (Leuplin DPS) treatment quarterly in patients with central precocious
puberty